Skip to main content

Biotron Limited

Antiviral Therapeutics. Biotron’s lead compound, BIT225, is in Phase 2 development for the treatment of HIV-1 and Hepatitis C virus infections.
https://www.redtoolbox.org/media/com_jbusinessdirectory/pictures/item/www_biotron_com_au.png
  • Details

Screen-Shot-2023-06-21-at-85921-am

Type
Business Organisation